Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Page, Karen ^a   Guttery, David S ^a   Zahra, Nathalie ^a   Primrose, Lindsay ^a   Elshaw, Shona R ^a   Pringle, J Howard ^a   Blighe, Kevin ^a   Marchese, Stephanie D ^b   Hills, Allison ^b   Woodley, Laura ^b   Stebbing, Justin ^b   Coombes, R Charles ^b   Shaw, Jacqueline A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ICTEM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING FREE DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; MICRORNA 159A; UNCLASSIFIED DRUG;

ADULT; AMPLICON; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; CENTRIFUGATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPLETION; DIFFERENTIAL CENTRIFUGATION FORCE; DNA EXTRACTION; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; NUCLEIC ACID ANALYSIS; ONCOGENE NEU; PLATELET DEPLETION; POLYMERASE CHAIN REACTION; QUALITATIVE ANALYSIS; QUALITATIVE RESEARCH; REPRODUCIBILITY; RNA ANALYSIS; RNA PROCESSING; VEIN PUNCTURE;

BLOOD SPECIMEN COLLECTION; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 84885704404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077963     Document Type: Article

References (31)

1. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ, (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650. PubMed: 837366.
2. Kuhlmann JD, Schwarzenbach H, Wimberger P, Poetsch M, Kimmig R, et al. (2012) LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival. BMC Cancer 12: 325. doi:10.1186/1471-2407-12-325. PubMed: 22849543.
3. Schwarzenbach H, Eichelser C, Kropidlowski J, Janni W, Rack B, et al. (2012) Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression. Clin Cancer Res 18: 5719-5730. doi:10.1158/1078-0432.CCR-12-0142. PubMed: 23014523.
4. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, et al. (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665. PubMed: 11245480.
5. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi:10.1073/pnas.0804549105. PubMed: 18663219.
6. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-D157. doi:10.1093/nar/gkr817. PubMed: 21037258.
7. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLOS ONE 3: e3148. doi:10.1371/journal.pone.0003148. PubMed: 18773077.
8. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, et al. (2009) Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLOS ONE 4: e6229. doi:10.1371/journal.pone.0006229. PubMed: 19597549.
9. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLOS ONE 3: e3694. doi:10.1371/journal.pone.0003694. PubMed: 19002258.
10. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487. doi:10.1016/S0140-6736(97)02174-0. PubMed: 9274585.
11. Page K, Hava N, Ward B, Brown J, Guttery DS, et al. (2011) Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer 104: 1342-1348. doi:10.1038/bjc.2011.89. PubMed: 21427727.
12. Page K, Powles T, Slade MJ, [!(surname)!], Walker RA, et al. (2006) The importance of careful blood processing in isolation of cell-free DNA. Ann N Y Acad Sci 1075: 313-317. doi:10.1196/annals.1368.042. PubMed: 17108226.
13. Shaw JA, Brown J, Coombes RC, Jacob J, Payne R, et al. (2011) Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomark Med 5: 87-91. doi:10.2217/bmm.10.118. PubMed: 21319970.
14. Shaw JA, Page K, Blighe K, Hava N, Guttery D, et al. (2012) Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res 22: 220-231. doi:10.1101/gr.123497.111. PubMed: 21990379.
15. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64. doi:10.1186/gb-2009-10-6-r64. PubMed: 19531210.
16. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, et al. (2013) Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 112: 595-600. doi:10.1161/CIRCRESAHA.111.300539. PubMed: 23283721.
17. Umetani N, Hiramatsu S, Hoon DS, (2006) Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci 1075: 299-307. doi:10.1196/annals.1368.040. PubMed: 17108224.
18. Su YH, Wang M, Brenner DE, Norton PA, Block TM, (2008) Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps. Ann N Y Acad Sci 1137: 197-206. doi:10.1196/annals.1448.027. PubMed: 18837947.
19. Sozzi G, Roz L, Conte D, Mariani L, Andriani F, et al. (2005) Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 97: 1848-1850. doi:10.1093/jnci/dji432. PubMed: 16368947.
20. Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, et al. (2001) Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47: 1607-1613. PubMed: 11514393.
21. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW, (2011) Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLOS ONE 6: e20769. doi:10.1371/journal.pone.0020769. PubMed: 21698099.
22. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840. doi:10.1373/clinchem.2010.157198. PubMed: 21487102.
23. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, et al. (2013) Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels. PLOS ONE 8: e64795. doi:10.1371/journal.pone.0064795. PubMed: 23762257.
24. Eldh M, Lötvall J, Malmhäll C, Ekström K, (2012) Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol 50: 278-286. doi:10.1016/j.molimm.2012.02.001. PubMed: 22424315.
25. Patel RS, Jakymiw A, Yao B, Pauley BA, Carcamo WC, et al. (2011) High resolution of microRNA signatures in human whole saliva. Arch Oral Biol 56: 1506-1513. doi:10.1016/j.archoralbio.2011.05.015. PubMed: 21704302.
26. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587. doi:10.1038/labinvest.2010.194. PubMed: 21116241.
27. van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, et al. (2012) Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 14: R34. doi:10.1186/bcr3127. PubMed: 22353773.
28. Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjøt L, et al. (2011) Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics 12: 435. doi:10.1186/1471-2164-12-435. PubMed: 21867561.
29. Jorde R, Svartberg J, Joakimsen RM, Coucheron DH, (2012) Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes 5: 245. doi:10.1186/1756-0500-5-245. PubMed: 22594500.
30. Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, et al. (2012) Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 14: 71-80. doi:10.1016/j.jmoldx.2011.09.002. PubMed: 22154918.
31. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, et al. (2012) Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer, 132: 1602-12. PubMed: 22927033.